… grading of dysplasia in Barrett esophagus (BE) shows substantial interobserver and
intraobserver variation. We used immunohistochemical analysis with a set of tumor cell markers, ie, …

… MUC2 and LI-cadherin are useful immunohistochemical markers for the … , Barrett’s mucosa,
IEN, and invasive carcinoma of the esophagus; however, none of the examined markers was …

… useful marker awaits larger series, and several fundamental challenges limit clinical
applicability of currently reported immunohistochemical markers. Currently, no single marker or …

… of Barrett's esophagus staining pattern with rising ZAP grade. Conclusion: CK7/20 is a feasible
marker for Barrett's esophagus. … regarding expression of immunohistochemical markers. …

… A biological marker affords an indication of the condition or disease… Immunohistochemical
evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus…

… There is currently no immunohistochemical marker that is specific to assist in defining the
anatomic site of the biopsy or resection sample. Careful histologic examination, with attention …

… A combination of MESH subject headings and text words were used related to IHC
markers for progression in patients with BE. The search was confined to English language …

… (LGD) within Barrett's esophagus (BE) has a multitude of ramifications. Identification of markers
that could … We aimed to prospectively evaluate the prognosis of the immunohistochemical …

… esophagus without goblet cells (n = 27), BE (n = 18), BE associated dysplasia (n = 16), and
EAC (n = 24). Standardized immunohistochemistry … utilization of this marker for the enhanced …

… treatments for Barrett esophagus. In this article, biological markers are reviewed for their
relevance in Barrett … staining (Figure 3), immunohistochemistry for p53 has been regarded as a …